FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileGlass House Brands Inc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
GLAS
Glass House Brands Inc Stock AnalysisComprehensive stock analysis for Glass House Brands Inc (GLAS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisGLAS
GLAS
Glass House Brands Inc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
GLAS
  1. Home
  2. Stocks
  3. Glass House Brands Inc

Glass House Brands Inc

🇺🇸GLAS•NYSE

Glass House Brands Inc

🇺🇸GLAS•NYSE
Market cap
$110.27M

Your view on GLAS

Mkt Cap
$110.27M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Glass House Brands Inc

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Kyle Kazan
Headquarters
3645 Long Beach Boulevard, Long Beach, CA, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Kyle Kazan
Headquarters
3645 Long Beach Boulevard, Long Beach, CA, US
Description

Glass House Brands, Inc. operates as an integrated cannabis company in the United States with focus on the California market and building brands to serve consumers across various segments. The company is involved in greenhouse cultivation operations, manufacturing practices, brand-building, and retailing activities.

The company offers its cannabis products through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell, Forbidden Flowers, and Mama Sue Wellness. The company was founded by Kyle Kazan, Graham Farrar and Jocelyn Rosenwald in 2015 and is headquartered in Long Beach, CA.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Glass House Brands Inc. Starting points for Glass House Brands Inc: EPS -$0.51, beta 0.51 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Glass House Brands Inc. Trailing twelve-month EPS for Glass House Brands Inc stands at -$0.51. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
Analysts' target$11.00average of analysts' targets
Current price—

Buy

Targets, low to high

$11.00

Low $7.00

Middle $11.00

High $15.00

Analyst ratings

1 rating
  • Strong Buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterSep 2024Next quarterDec 2024This yearYear to Dec 2024Next yearYear to Dec 2025
Average estimate$0.01−$0.10−$0.35−$0.41
Lowest estimate$0.00−$0.11−$0.37−$0.43
Highest estimate$0.01−$0.10−$0.34−$0.39
Number of analysts1111
A year ago————
Growth vs a year ago————

Revenue estimates

TotalThis quarterSep 2024Next quarterDec 2024This yearYear to Dec 2024Next yearYear to Dec 2025
Average estimate$65.80M$50.38M$199.14M$182.38M
Lowest estimate$61.45M$47.95M$192.73M$176.51M
Highest estimate$69.59M$52.81M$207.77M$190.28M
Number of analysts1111
A year ago————
Growth vs a year ago————
Recent rating and target changes (3)

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Glass House Brands Inc. Glass House Brands Inc has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold GLAS12 companies
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
XTXXFAdastra Holdings Ltd.HealthcareOTC$55,971
YCBDcbdMD, Inc.HealthcareAMEX$4.0M
YOURFYourWay Cannabis Brands Inc.HealthcareOTC$2,879
ZTSZoetis Inc.HealthcareNYSE$32.1B
ZYBTZhengye Biotechnology Holding LimitedHealthcareNASDAQ$70.1M
TSND.TOTerrAscend Corp.HealthcareTSX$160.1M
TSNDFTerrAscend Corp.HealthcareOTC$259.7M
TWAPFTowa Pharmaceutical Co., Ltd.HealthcareOTC$828.5M
TWSITristar Wellness Solutions Inc.HealthcareOTC$1.9M
TXMDTherapeuticsMD, Inc.HealthcareNASDAQ$19.8M
ULIHFThe United Laboratories International Holdings LimitedHealthcareOTC$3.2B
UPCUniverse Pharmaceuticals Inc.HealthcareNASDAQ$682,302
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Glass House Brands Inc executives and directors. Shares of Glass House Brands Inc have traded between $9.12 and $13.19 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Glass House Brands Inc. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Glass House Brands Inc. Coverage tracks Glass House Brands Inc within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Glass House Brands Inc.

GLAS AnalysisWeak
Past
1
Growth
2
Health
4
Profit
1
Value
1